Peripheral Facial Palsy
Conditions
Keywords
Peripheral Facial Palsy, Stellate Ganglion Block, Facial Nerve Block
Brief summary
Peripheral facial palsy is caused by damage to the facial nerve at any site of the peripheral branches after the facial nucleus.Stellate ganglion block is performed to treat peripheral facial palsy because it increases blood flow and promotes nerve regeneration.Facial Nerve Block worked with elimination of local inflammation of nerve and oppression. Facial nerve block is a treatment that inject drugs into the damaged nerve around to eliminate local inflammation and compression of the nerve.
Interventions
PROCEDUREStellate Ganglion Block
Patients underwent a stellate-ganglion block at the anterolateral aspect of the C6 vertebra. After local analgesia (lidocaine 2%), a 22-gauge Quincke needle was placed in the anterolateral aspect of the C6 vertebral body. When the needle contacted the bone, it was drawn back 1 mm. 5 mL of 0·5% ropivacaine was subsequently injected next to the stellate ganglion to produce a sympathetic block.The effect of the stellate-ganglion block on the sympathetic nervous system was confirmed by the presence of Horner's syndrome (ie, facial anhydrosis, enophthalmos, ptosis, swelling of the lower eyelid, miosis, and blood-shot conjunctiva), and an increase in the temperature of the right hand of at least 2°F from baseline.
PROCEDUREFacial Nerve Block
Operator touching the location of the mastoid, in the external auditory canal just below the front of the mastoid vertical needling.When touch the surface of the mastoid,adjust the needle across the front of the mastoid then slow needling about 1cm.The pin located below the stylomastoid foramen, and then injected drugs 5mL ( mecobalamin injection 1mg；lidocaine 60mg； dexamethasone 10mg )
oral Mecobalamin Tablets tid-8
Sponsors
Zhuan Zhang
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
Diagnosed by clinical and neurological assessment as one-sided simple facial * Age 18 to 75 years * HBGS above Ⅳ * the course of IFP not over 7 days.
Exclusion criteria
* Coagulation dysfunction * plate plate plate shape, quantity or abnormal function * mental system diseases * Gillan-Bahrain syndrome * cancer, mumps, shingles infection, jaw facial pus lymph nodeitis, encephalitis, -cerebral hemorrhage and other diseases * local infection or systemic infectious disease at the puncture site * can not accept to nerve block
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline House-Brackmann | Baseline ,change from baseline House-Brackmann at 3 days,6 days,9 days,14 days,one month,two month | The House-Brackmann scale is a nerve grading system developed in 1985 by Los Angeles otolaryngologists Dr. John W. House and Dr. Derald E. Brackmann. It is used to characterize the severity of a facial paralysis patient's symptoms. |
| Change from Baseline Sunnybrook | Baseline,change from baseline Sunnybrook at 3 days,6 days,9 days,14 days, one month,two month | Sunnybrook is a new facial nerve function of subjective assessment system.It is based on both static and dynamic aspects. |
Countries
China
Outcome results
None listed